ABOUT US
BMG-Research is a Swiss early phase clinical trial unit located in Zurich and linked to The Bellevue Medical Group (BMG), a leading interdisciplinary network of neurological and neuropsychological competence centers.
BMG-Research conducts state of the art early-phase clinical trials in multiple sclerosis and other neurological diseases for local and international customers.
Mission
To conduct innovative proof-of-concept and mechanism-oriented Phase I-II clinical trials for neurological diseases within a dedicated translational research center. Our approach combines state-of-the-art patient care with unique mechanistic profiling and biomarker development.
Key Values
Focus
-
Highly specialized in designing and executing early phase clinical trials with innovative study designs.
-
Unique knowledge in mechanistic profiling and biomarker development.
-
Excellent care of trial participants in a dedicated Clinical Center.
Track record
-
Proven expertise in conducting complex and high-impact clinical trials.
-
Well-known translational expertise in treatment development, particularly design and conduct of innovative, complex clinical trials.
Partnership
Strong collaboration with global research institutions, clinical centers and patient organizations.
Trusted reputation among patients and patient organizations.